Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 2
2006 2
2007 1
2009 1
2010 2
2011 1
2012 2
2013 1
2015 2
2016 1
2017 2
2018 2
2019 1
2020 1
2021 3
2022 3
2023 2
2024 6
2025 4
2026 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

44 results

Results by year

Filters applied: . Clear all
Page 1
Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trial.
Spicer JD, Garassino MC, Wakelee H, Liberman M, Kato T, Tsuboi M, Lee SH, Chen KN, Dooms C, Majem M, Eigendorff E, Martinengo GL, Bylicki O, Rodríguez-Abreu D, Chaft JE, Novello S, Yang J, Arunachalam A, Keller SM, Samkari A, Gao S; KEYNOTE-671 Investigators. Spicer JD, et al. Lancet. 2024 Sep 28;404(10459):1240-1252. doi: 10.1016/S0140-6736(24)01756-2. Epub 2024 Sep 14. Lancet. 2024. PMID: 39288781 Free PMC article. Clinical Trial.
Perioperative Pembrolizumab for Early-Stage Non-Small-Cell Lung Cancer.
Wakelee H, Liberman M, Kato T, Tsuboi M, Lee SH, Gao S, Chen KN, Dooms C, Majem M, Eigendorff E, Martinengo GL, Bylicki O, Rodríguez-Abreu D, Chaft JE, Novello S, Yang J, Keller SM, Samkari A, Spicer JD; KEYNOTE-671 Investigators. Wakelee H, et al. N Engl J Med. 2023 Aug 10;389(6):491-503. doi: 10.1056/NEJMoa2302983. Epub 2023 Jun 3. N Engl J Med. 2023. PMID: 37272513 Free PMC article. Clinical Trial.
Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial.
Mok TSK, Wu YL, Kudaba I, Kowalski DM, Cho BC, Turna HZ, Castro G Jr, Srimuninnimit V, Laktionov KK, Bondarenko I, Kubota K, Lubiniecki GM, Zhang J, Kush D, Lopes G; KEYNOTE-042 Investigators. Mok TSK, et al. Lancet. 2019 May 4;393(10183):1819-1830. doi: 10.1016/S0140-6736(18)32409-7. Epub 2019 Apr 4. Lancet. 2019. PMID: 30955977 Clinical Trial.
Safety, efficacy, and analysis of biomarkers in patients with advanced non-small cell lung cancer treated with the anti-IL1RAP antibody nadunolimab (CAN04) in combination with platinum doublet.
Paulus A, Zemaitis M, Cicenas S, Zvirbule Z, Sanfridson A, Millrud CR, Magnusson S, Losic N, Tersago D, Garcia-Ribas I, Thorsson L, Paz-Ares LG. Paulus A, et al. Among authors: zemaitis m. Lung Cancer. 2025 Aug;206:108664. doi: 10.1016/j.lungcan.2025.108664. Epub 2025 Jul 14. Lung Cancer. 2025. PMID: 40680438 Free article. Clinical Trial.
Treatment Outcomes for Malignant Peripheral Lung Tumours: A Prospective Single-Centre Comparison of Thermal Ablation, Surgery, and Radiotherapy.
Mačionis A, Maziliauskienė G, Dubeikaitė R, Balčiūnaitė I, Galnaitienė G, Padervinskienė L, Matulionė J, Miliauskas S, Korobeinikova E, Jaruševičius L, Nedzelskienė I, Mišeikytė-Kaubrienė E, Vajauskas D, Žemaitis M. Mačionis A, et al. Among authors: zemaitis m. Medicina (Kaunas). 2025 Nov 3;61(11):1972. doi: 10.3390/medicina61111972. Medicina (Kaunas). 2025. PMID: 41303809 Free PMC article.
Real-World Impact of Initial Dual Bronchodilation on Exercise Physiological Response and Health-Related Quality of Life in Newly Diagnosed, Treatment-Naïve Chronic Obstructive Pulmonary Disease.
Dimiene I, Hoppenot D, Rimkunas A, Vaguliene N, Bieksiene K, Zemaitis M, Malakauskas K, Miliauskas S. Dimiene I, et al. Among authors: zemaitis m. Medicina (Kaunas). 2026 Mar 12;62(3):531. doi: 10.3390/medicina62030531. Medicina (Kaunas). 2026. PMID: 41901612 Free PMC article.
Lung cancer screening in Lithuania: a cost-effectiveness analysis.
Berge HT, Piazza G, Ramaker D, Pan X, Bukšnys T, Cicėnas S, Miliauskas S, Smailyte G, Zablockis R, Zemaitis M, Danila E. Berge HT, et al. Among authors: zemaitis m. J Comp Eff Res. 2026 Aug;15(8):e260034. doi: 10.57264/cer-2026-0034. Epub 2026 Jul 16. J Comp Eff Res. 2026. PMID: 42460841 Free PMC article.
44 results